Drugmakers pushed aggressive diabetes therapy. Patients paid the price.
Pharmaceutical giants launched years-long marketing campaigns for a treatment target they helped create, and as their sales of diabetes drugs soared, so did incidents of low blood sugar, a potentially deadly medication risk.
By ROBIN RESPAUT, CHAD TERHUNE and DEBORAH J. NELSON
How drugmakers pushed diabetes patients into a danger zone (reuters.com)
